The patient as consumer: The advertising of pharmaceuticals directly to consumers should be allowed and encouraged

Economic Affairs

Volumn 27, Issue 2, 2007, Pages 64-72

  Auton, Frank ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250707320     PISSN: 02650665     EISSN: 14680270     Source Type: Journal    
DOI: 10.1111/j.1468-0270.2007.00732.x     Document Type: Article

References (35)

1. ABPI (Association of the British Pharmaceutical Industry of Great Britain) (2004) Facts and Statistics from the Phamaceutical Industry - A Global Industry, Available at http://www.abpi.org.uk/statistics/ section.asp?sect=1#3.
2. Allison-Ottey, S. (2003) DTC and the AA Physician and Patient, Washington, DC, 22 September 2003. Available at: http://www.fda.gov/cder/ ddmac/P1AllisonOttey/index.htm.
3. American Diabetes Association (1997) Michael Jonathan Grinfeld, 'Ad Campaign Targets Depression', Psychiatric Times, XIV, September, Issue 9, National Cholesterol Education Program.
4. Auton, F. (2004) 'The Advertising of Pharmaceuticals Direct to Consumers: A Critical Review of the Literature and Debate', International Journal of Advertising, 23, 1, 23-52.
5. Bennet, G. (1979) Patients and their Doctors: The Journey Through Medical Care, London: Ballière Tindall.
6. Benson, R. (2001) 'DTC - Beyond the US Horizon', Healthworld Communications Group, News and Views, May.
7. Calfee, J. (2002) 'Public Policy Issues in Direct to Consumer Advertising of Prescription Drugs', Journal of Public Policy and Marketing, 21, 2, 174-193.
8. Cardy, P., H. Clayton, B. Edwards and M. Gay (1999) Keeping the Patient in the Dark, London: Institute of Economic Affairs.
9. CHC (Coalition for Healthcare Communication) (2004) 'Comments of the CHC before the US FDA in the Matter of Consumer Directed Promotion', Docket No. 2003N-0344. Available at http://www.ana.net/news/2004/ FinalCHCComments.pdf.
10. Collins, R., J. Armitage, S. Parish, P. Sleight and R. Peto (2002) 'MRC/ BHF Heart Protection Study of Cholesterol-lowering with Simvastatin in 20536 High-risk Individuals: A Randomised Placebo-controlled Trial', Lancet, 360, 7-22.
11. Donahue, J., E. Berndt, M. Rosenthal, A. M. Epstein and R. G. Frank (2004) 'Effects of Pharmaceutical Promotion on Adherence to Treatment Guidelines for Depression', Medical Care, 42, 12, 1176-1185.
12. Downs, J. R., M. Clearfield, S. Weis, E. Whitney, D. Shapiro, P. Beere, A. Langendorfer, E. Stein, W. Kruyer and A. Grotto (1998) 'Primary Prevention of Acute Coronary Events with Lovastatin in Men and Women with Average Cholesterol Levels: Results of AFCAPS/TexCAPS', JAMA, 279, 20, 1615-1627.
13. FDA (2003) 2002 Physician Survey, Rockville, MD: FDA.
14. FDA (2004) Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Prescription Drugs - Summary of FDA Survey Research Results. Available at http://www.fda.gov/cder/ddmac/Final%20Report/ FRfinal111904.pdf.
15. FDA Guidance for Industry (1999) Consumer Directed Broadcast Advertisements, Rockville, MD: FDA.
16. Federal Trade Commission Workshop (2002a) DTCA - Is it Helping or Hurting?, Washington, DC: FTC.
17. Federal Trade Commission Workshop (2002b) Direct-to-Consumer Prescription Drug Advertising, Washington, DC: FTC.
18. Gay, H. (1999) Keeping the Patient in the Dark, London: Institute of Economic Affairs.
19. HAI (Health Action International) (2001) The European Commission's Proposals for Legislative Change, Amsterdam: HAI.
20. Harlan, K., J. Radford, Y. Wang, J. Chen, A. Heiat and A. Marciniak (1998) 'National Use and Effectiveness of β-Blockers for the Treatment of Elderly Patients after Acute Myocardial Infarction. National Cooperative Cardiovascular Project'. JAMA, 280, 623-629.
21. Herrnstein, M. (2004) 'How Consumers Attitudes toward DTCA Influence Ad Effectiveness and Consumer and Physician Behaviour', Marketing Letters, 15, 4, 201-212.
22. Hirschfeld, R., M. Keller, S. Panico, B. Arons, B. Davidoff, J. Endicott, J. Froom, M. Goldstein, J. Gorman, R. Marek, T. Maurer, T. Meyer, K. Phillips, J. Ross, T. Schwenk, S. Sharfstein, M. Thase and R. Wyatt (1997) 'The National Depressive and Manic-Depressive Association Consensus Statement on the Under Treatment of Depression', National Depressive and Manic-Depressive Association, Chicago, IL, JAMA, 277, 4, 333-340.
23. Hone, F. and R. Benson (2004) 'DTC European Style', Pharmaceutical Executive, 1 March. Available at http://www.pharmaexec.com/pharmexec/ content/printContentPopup.jsp?id=87982.
24. IMS Health (2005a) IMS Health Topline Industry Data 2005, Global Pharmaceutical Sales 1998-2005. Available at http://www.imshealth.com/ ims/portal/front/articleC/0,2777,6599_77478579_77478598,00.html.
25. IMS Health (2005b) IMS Health Topline Industry Data 2005, Global Pharmaceutical Sales by Region 2005. Available at http://www.imshealth.com/ims/portal/front/articleC/ 0,2777,6599_77478579_77479643,00.html.
26. International Osteoporosis Foundation (2001) Osteoporosis in the European Union: Overview and Next Steps. Available at http://www.osteofound.org/advocacy_policy/eu_policy_project/pdf/ overview_next_steps.pdf.
27. Lichtenberg, F. (2002) Benefits and Costs of Newer Drugs, Cambridge, MA: National Bureau of Economic Research.
28. Mertens, G. (1998) 'Direct to Consumer Advertising', Financial Times, p. 63.
29. National Consumers League (1998) Health Care Information and the Consumer: A Public Opinion Survey, Washington, DC: National Consumers League.
30. Pfizer (2001) Impact of DTCA on Patient Compliance. Available at http://www.pfizer.com.
31. Slaughter, E. and M. Schumacher (2000/01) 'Prevention's International Survey on Wellness and Consumer Reactions to DTCA of Rx Drugs', Prevention Magazine, Emmaus, PA: Rodale Press.
32. Theodore, R. and H. Parmar (2005) 'Pharmaceutical DTCA in Europe', Pharmaceutical Field, December, pp. 16-17.
33. Toshiaki, L. and J. Ginger Zhe (2005) 'The Effect of Prescription Drug Advertising on Doctors', Journal of Economics and Management Strategy, 14, 3, 701-727.
34. Tufts Center for the Study of Drug Development (2002) 'Disease Managers Say Increased Spending on Prescription Drugs Reduces Inpatient Costs', Press Release, 12 March 2002.
35. Weissman, J., D. Blumenthal, A. Silk, K. Zapert, M. Newman and R. Leitman (2003) 'Consumers' Reports on the Health Effects of Direct-to-Consumer Drug Advertising', Health Affairs Web Exclusive, 26 February.